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Cardiovascular disease (CVD) is the leading cause of death in industrialized nations and
an emerging health problem in the developing world. Systemic inflammatory processes
associated with alterations in lipid metabolism are a major contributing factor that
mediates the development of CVDs, especially atherosclerosis. Therefore, the pathways
promoting alterations in lipid metabolism and the interplay between varying cellular types,
signaling agents, and effector molecules have been well-studied. Mycobacterial species
are the causative agents of various infectious diseases in both humans and animals.
Modulation of host lipid metabolism by mycobacteria plays a prominent role in its survival
strategy within the host as well as in disease pathogenesis. However, there are still
several knowledge gaps in the mechanistic understanding of how mycobacteria can
alter host lipid metabolism. Considering the in-depth research available in the area of
cardiovascular research, this review presents an overview of the parallel areas of research
in host lipid-mediated immunological changes that might be extrapolated and explored
to understand the underlying basis of mycobacterial pathogenesis.
Keywords: mycobacterium, tuberculosis, granuloma, lipid, cardiovascular, plaque, arachidonic acid, foam cell

INTRODUCTION
One of the leading causes of morbidity and mortality in westernized countries is cardiovascular
disease (CVD), such as atherosclerosis (Yeates et al., 2015). Atherosclerosis is a complex, chronic,
progressive, inflammatory disease involving different cell types resulting in the formation of an
atheromatous plaque. Atherosclerosis is characterized by infiltration of the arterial intima by
macrophages which scavenge oxidized low density lipoprotein (oxLDL), which further promotes
alterations in cholesterol influx, esterification and efflux, ultimately resulting in the progression of
the macrophage into a foam cell. The specific contributions of lipids and lipoproteins as well as the
influence of cholesterol metabolism in the formation of atheromatous plaques has been extensively
researched in the context of atherosclerosis and CVD (Chroni et al., 2011).
Mycobacterium tuberculosis (Mtb) is a successful human pathogen due to its ability to
cause tuberculosis (TB) in almost 10 million individuals annually (Dye and Williams, 2010).
Non-tuberculous mycobacteria (NTM) also cause diseases such as pulmonary and skin infections,
in addition to being implicated as putative causative agents of Crohn’s disease in humans
(Thirunavukkarasu et al., 2017a). NTM share commonalities with tuberculous mycobacteria
with regard to subversion of host macrophage immune responses (Whittington et al., 2012;
Thirunavukkarasu et al., 2017a). A primary reason for the ubiquitous spread of mycobacterial
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infection despite current control strategies is the ability of
pathogenic mycobacteria to persist in a non-replicative state both
within the host, and sometimes in the environment (Falkinham,
2009). Macrophages play a pivotal role in the immune response
against mycobacteria (Pieters, 2008; Thirunavukkarasu et al.,
2015; Mcclean and Tobin, 2016). One of the main mechanisms
of the successful intra-macrophage survival of mycobacteria
including Mtb, M. avium, M. bovis, M. paratuberculosis, M.
ulcerans, and M. leprae is their capacity to manipulate the
host cellular metabolism to utilize intracellular substrates
including fatty acids and cholesterol (Mendum et al., 2015).
This manipulation of the host macrophage lipid metabolic
pathway is a hallmark of several mycobacterial infections
including TB (Peyron et al., 2008; Russell et al., 2009; Almeida
et al., 2012; Caire-Brändli et al., 2014). Dysregulated lipid
metabolism resulting in foam cell formation in macrophages
and other cell types, and its association with steroid hormones
as well as granuloma lesion formation, is a critical aspect in
understanding mycobacterial pathogenesis. However, current
research on the contribution of host lipid metabolic pathways in
disease pathogenesis is limited, unlike in cardiovascular research
where it has been the focus of extensive studies (Tambo et al.,
2016). The similarities in the immune responses in the kinetics
of atherosclerotic plaque formation and a granuloma formation
in TB is an exposition of how knowledge could be gained by
extrapolating ideas from among these fields.
NIH has identified interdisciplinarity as an essential
contributor to needed knowledge and made it an explicit
priority in its roadmap. Considering the several areas of
similarities between the immunopathology of atherosclerosis
and mycobacteriosis, it would be applicable to explore and
extrapolate the plethora of information available in this arena
in CVD research to address the knowledge gaps in the area
of host lipid metabolism in mycobacterial research. However,
comprehensive review articles providing reference pools for
promoting scientific knowledge in interdisciplinary applications
between CVD and mycobacterial immunopathology are
lacking. Therefore, the purpose of this review is to identify
and put forth the similarities in relation to alterations in host
lipid metabolism contributing to disease pathology induced
by cardiovascular and mycobacterial diseases. Furthermore,
we highlight the recent advances pertaining to host lipid
metabolism in CVD immunopathology that could provide
potential avenues to explore for researchers involved in studying
mycobacterial pathogenesis.

processing and retention of intracellular lipids, and altered
reverse cholesterol transport (Remmerie and Scott, 2018). Lipids
are not soluble in plasma and circulating lipids are transported
to various tissues in the form of lipoproteins. Additionally, lipids
can also circulate in blood in an albumin bound manner and can
be taken into macrophages via micropinocytosis in a receptor
independent manner (Kruth, 2013).
Lipoproteins are complex particles made up of a central
hydrophobic core of non-polar lipids, primarily cholesterol
esters, and triacyl glycerides (TAG). This hydrophobic core
is surrounded by a hydrophilic membrane consisting of
phospholipids, free cholesterol, and apolipoproteins (Chistiakov
et al., 2017). Based on size and concentration, lipoproteins are
classified as chylomicrons, very low density lipoproteins (VLDL),
low density lipoproteins (LDL), or high density lipoproteins
(HDL). LDL particles transport cholesterol esters, by associating
with apolipoproteins B-100 and C-III, and are taken up inside the
cell via the low density lipoprotein receptor (LDLR) (Rosenson
et al., 2011). Once inside, LDL is digested inside lysosomes
and free cholesterol is released. Free cholesterol can then either
move to the membrane surface and undergo efflux via ATPbinding cassette transporter (ABC) A1 or ABCG1, or enter
the endoplasmic reticulum (ER) where they are esterified to
form lipid droplets by acyl CoA acetyl transferase 1 (ACAT-1)
(Chistiakov et al., 2017). Free cholesterol could also cause
peristent stress to the ER which ultimately results in excess
nuclear factor kappa B (NFκB) signaling and apoptosis. Excess
free cholesterol inside the cells can also result in the formation of
cholesterol crystals, leading to enrichment of the cell membrane
lipid rafts causing toll-like receptor (TLR) activation, and
downstream signaling events (Remmerie and Scott, 2018).
LDL also undergoes oxidation resulting in the formation
OxLDL. The sub-endothelial space is considered to be the site
of LDL oxidation as the antioxidant properties of blood prevents
LDL oxidation while in circulation (Matsuura et al., 2008).
LDL modification to OxLDL occurs by multiple mechanisms
including oxidative and nitrosative stress (ROS and NOS)
as well as enzymes like 12/15 lipoxygenases (LOX) and
secretory phospholipase A2 (sPLA2) (Linton et al., 2015).
OxLDL comprises of a variety of by-products arising due
to the modification of both lipids and apolipoprotein B by
lipid peroxidation (Matsuura et al., 2008). OxLDL is taken up
preferentially by the macrophages by endocytosis, via scavenger
receptors such as CD36, macrophage receptor with collagenous
structure (MARCO), scavenger receptor B1 (SR-B1), and LOX1,
as well as CD14-Toll like receptor 4-MD2 complex (Kruth, 2001).
This induces ROS generation, cytokine secretion, production of
myeloperoxidase, and 12/15 lipoxygenase secretion which further
oxidize new LDL thus increasing the local pool of oxLDL. The
components of oxLDL also act as ligands for the peroxisome
proliferator activated receptor gamma (PPARγ) which in turn
increases the intake of more OxLDL via upregulation of CD36.

MACROPHAGE INTRACELLULAR LIPID
METABOLISM AND FOAM
CELL FORMATION
A key feature in atherosclerosis and mycobacteriosis is the
presence of lipid laden cells called foam cells (Kruth, 2001; Chen
et al., 2008; Almeida et al., 2012; Bah et al., 2017). The process
of foam cell formation is directly or indirectly influenced by
uptake of native or modified lipoproteins by cell types present
in atheromatous lesions especially macrophages, subsequent

Frontiers in Cellular and Infection Microbiology | www.frontiersin.org

Abbreviations: CVD, cardiovascular disease; TB, tuberculosis; Mtb,
Mycobacterium tuberculosis; AA, arachidonic acid; COX, cyclooxygenase;
LOX, lipoxygenase; CYP, Cytochrome; oxLDL, oxidized low density lipoprotein;
PGE2, Prostaglandin E2; IFN, interferon.

2

April 2019 | Volume 9 | Article 116

Thirunavukkarasu and Khader

Interdisciplinary Knowledge and Mycobacterial Pathogenicity

inflammatory cell infiltration with a thick fibrous cap or an
unstable plaque characterized by a necrotic core of foamy
macrophages, degradation of the collagenous fibrous cap by
matrix metalloproteinases, and subsequent rupture of the plaque
necrotic core (Kruth, 2001). Several enzymes including those
belonging to the Cyp family play crucial roles in the generation of
either a stable plaque or progression to an unstable plaque with
poor prognosis for atherosclerosis outcome (Silvestre-Roig et al.,
2014; Song et al., 2016; Stefanadis et al., 2017).
The stability of the atheromatous plaques formed directs
disease outcome in atherosclerosis (Chen et al., 2016).
Similarly, many mycobacterial infections including Mtb, M.
paratuberculosis, M. bovis, and M. marinum are characterized
by granuloma formation, the relative stability and organization
of which impacts disease severity and outcome (Wangoo et al.,
2005; Silva Miranda et al., 2012; Wu et al., 2012; Guirado and
Schlesinger, 2013; Fernández et al., 2016). Granulomas are
formed as organized aggregates of immune cells composed
primarily of infected and uninfected macrophages, foamy
macrophages, and other cell types including NK cells and DCs
that are surrounded by a ring of B and T lymphocytes (Silva
Miranda et al., 2012). Granulomas are formed as a means to
control chronic mycobacterial infection, but progression to
cavitary granuloma leads to subclinical and clinical disease
(Guirado and Schlesinger, 2013). Thus, the TB granuloma is
categorized as either stable wherein the bacteria are contained
and infection is mostly latent or as a disorganized granuloma
with a necrotic caseous core, matrix metalloproteinase-mediated
loss of the collagen layer, and dissemination of infection leading
to active TB with a much poorer prognosis (Kim et al., 2010;
Russell et al., 2010). Although there are differences between an
atherosclerotic plaque and TB granuloma regarding the role
of T cells and B cells, similarities in dysregulated host lipid
metabolism which contribute to disease pathogenesis are indeed
conspicuous in both diseases (Figure 3).
Cholesterol catabolism, apart from providing a potent
source of carbon for mycobacterial metabolism (Wilburn
et al., 2018), also results in the production of propionyl
CoA and methylmalonyl CoA that are used for the synthesis
of mycobacterial cell wall virulence components such as
phthiocerol dimycocerosate (PDIM) (Jain et al., 2007), and
sulpholipids (Pandey and Sassetti, 2008; Griffin et al., 2012;
Abuhammad, 2017). Since cholesterol modulates mycobacterial
metabolism, identification of novel targets in the cholesterol
metabolic pathway has been carried out for the purpose of
chemotherapeutic intervention of TB (Vanderven et al., 2015).
Moreover, the modulation of host cholesterol can have adverse
effects on several host signaling mechanisms as well as cellular
immune polarization. It is believed that lipid mediated signaling
via the sterol regulatory element binding protein 1 leads
to a pro-inflammatory M1 phenotype in macrophages while
signaling via LXR leads to an anti-inflammatory M2 phenotype
(Tangirala et al., 2002). Cholesterol also acts as a substrate
for various enzyme activities including those belonging to the
Cyp family (Pikuleva, 2006; Rogers et al., 2015). Furthermore,
cholesterol is also a precursor for major sex hormones and a
role for sex differences in the host immune responses to CVD
(Jennings et al., 2014; Pingili et al., 2015) and mycobacterial

Moreover, accumulating oxLDL blocks the PPARγ mediated liver
X receptor (LXR) signaling which favors cholesterol efflux due
to upregulation of ABCA1. The events result in the macrophage
transforming into a foam cell (Figure 1). Internalization of
OxLDL by CD36 decreases macrophage migration and activates
focal adhesion kinases. Therefore, OxLDL contributes to both
macrophage activation as well as retention (Parthasarathy
et al., 2010). In addition, OxLDL increases platelet derived
growth factor (PDGF) and other growth factors secretion thus
amplifying cellular proliferation. The OxLDL mediated ROS
generated triggers the cytochrome c mediated apoptosis cascade
leading to cellular death and debris accumulation (Leiva et al.,
2015). This coupled with a malfunctioning lipid metabolic
pathway can impact the apoptotic cell clearance by other
macrophages resulting in chronic inflammation (Szondy et al.,
2014), which may further enhance foam cell formation. Mtb
which enter the host macrophages has the capacity to utilize host
cholesterol and also sequester host fatty acids in the form of TAG
within intra-bacterial lipid inclusion bodies believed to occur
via bacterial mce transporters mediated by Rv3723/LucA (Pandey
and Sassetti, 2008; Daniel et al., 2011; Nazarova et al., 2017). This
lipid accquisition is required for bacterial persistence especially
in the chronic phase of disease (Neyrolles, 2014).
Since foam cell formation is an essential aspect of the
immunopathology of both atherosclerosis and several
mycobacterial infections, the knowledge regarding the lipid
mediators, and signaling events that contribute to this are
of interest.

Arachidonic Acid and Lipid Mediators
OxLDL activates phospholipase enzymes which act on membrane
phospholipids releasing arachidonic acid (AA) (Akiba et al.,
2003). Arachidonic acid is the substrate from which the
biologically active lipid mediators belonging to the eicosanoid
family are produced due to the activity of various enzymes
(Akiba et al., 2003). These enzymes belong to three pathways,
namely (a) the COX pathway (COX1, COX2) resulting in
production of prostaglandins (PG), (b) the LOX pathway
(5-LOX, 1LOX, 15LOX) resulting in production of leukotrienes
(LTs) and lipoxins (LXs), and (c) the cytochrome P450 (Cyp)
pathway which forms the hydroxyeicosotetranoic acids (HETEs)
and the epoxyeicosotrienoic acids (EETEs) (Hanna and Hafez,
2018). Non-enzymatic lipid peroxidation of AA results in the
production of isoprostanes and isoketals. PGs and LTs are the
initial mediators which recruit neutrophils and monocytes to the
site of inflammation (Dietzold et al., 2015). The importance and
involvement of PGE2 and other lipid mediators and the signaling
events of the arachidonic acid metabolic pathway (Figure 2)
in CVDs in general and atherosclerosis in particular has been
extensively explored utilizing several approaches which could
offer insight for mycobacterial researchers to pursue.

LESION: ATHEROSCLEROTIC PLAQUE VS.
TB GRANULOMA
An atherosclerotic plaque formed as a result of dysregulated
lipid metabolism is either stable and characterized by low
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org
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FIGURE 1 | Mechanism of foam cell formation. LDL is taken up inside the cell via the low density lipoprotein receptor (LDLR). Digestion of the cholesterol esters (CE)
in LDL inside the lysosome releases free cholesterol (FC) which undergoes efflux via ATP-binding cassette transporter (ABC) A1 or ABCG1, or enter the endoplasmic
reticulum (ER) where they are esterified to form lipid droplets by acyl CoA acetyl transferase 1 (ACAT-1) FC could also cause persistent stress to the ER which
ultimately results in excess nuclear factor kappa B (NFkB) signaling and apoptosis. Excess FC inside the cells can also result in the formation of cholesterol crystals
(CC) causing toll-like receptor (TLR) activation and downstream signaling events. OxLDL is taken up via scavenger receptors such as CD36, scavenger receptor B1
(SRB1) and LOX1, and induces ROS generation and cytokine secretion. Components of oxLDL are ligands for the peroxisome proliferator activated receptor gamma
(PPARγ) which increases the intake of more OxLDL via upregulation of CD36. Activation of PPARγ triggers liver X receptor signaling which facilitates lipid efflux via
upregulation of ABCAI, blocking of this pathway along with accumulation of OxLDL/FC results in the macrophage transforming into a foam cell. Mycobacteria entering
the cell via the cell surface receptors are taken up by phagosomes and associate with lipid droplets and assimilate them facilitating their survival in the host cell whose
lipid metabolism is further impacted by the mycobacteria.

asymptomatic but well-contained disease forms in the early
stages of infection are classified as incipient disease while the
asymptomatic disease at the latent end of the spectrum associated
with loss of effective containment is termed as subclinical TB
(Achkar and Jenny-Avital, 2011). Several studies have reported
on the role of host and pathogen derived lipids both in vitro and
in vivo in disease pathogenicity caused by mycobacterial sp. in
general, and Mtb in particular (Guenin-Mace et al., 2009; Philips
and Ernst, 2012; Lee et al., 2013; Thirunavukkarasu et al., 2014,
2016a). Thus, the modulation of the host lipid metabolism could
have an impact on the different stages of the TB disease spectrum,
including granuloma formation. In the following sections we
provide a snapshot of the lipid mediators and pathways that affect
TB disease progression and outcome.

infections (Neyrolles and Quintana-Murci, 2009; Bini et al.,
2014; Karunasena et al., 2014; Nhamoyebonde and Leslie, 2014;
Mirsaeidi and Sadikot, 2015; Dibbern et al., 2017), has been
of interest in recent years, with men reportedly being more
susceptible than women to CVD as well as mycobacterial
infection. In this context, it is important to note that although
a role for sex steroid hormones in influencing susceptibility to
pulmonary tuberculosis has also been established (Bini et al.,
2014), it has not been researched indepth as is the case
in CVD.

ROLE OF LIPID METABOLISM IN
MYCOBACTERIAL PATHOGENESIS
The outcome of initial exposure of Mtb in the human host
could either result in the pathogen progressing to primary
active TB disease or efficient elimination through an innate
and/or acquired immune response. Mycobacteria could also
survive inside the host in a non-replicative state but capable
of reactivation and subsequent progression to the active form
of disease. The active phase of TB infection is characterized
by the formation of caseous granulomas and cavities which are
correlated with failure of control and disease relapse (Russell
et al., 2010). The progression of human TB infection, from latent
infection to active disease, occurs as a continuous spectrum of
metabolic bacterial activity amidst the onslaught of protective
host immune responses (Drain et al., 2018). Furthermore, the
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Role of Lipid Mediators in TB Progression
Foamy macrophages formed during the course of mycobacterial
infection are rich sites of PGE2 generation (Almeida et al.,
2009) and therefore cross regulation of eicosanoid pathways
could play a critical role in controlling the growth of pathogenic
mycobacteria. PGE2 is an important lipid mediator as it has
the potential to regulate its own production, while suppressing
acute inflammatory mediators, resulting in its predominance
at late/chronic stages of immunity during a wide range of
autoimmune, metabolic, and infectious diseases (Kalinski, 2012).
Therefore, inhibition of PGE2 production and signaling could
potentially represent a therapeutic alternative to treat bacterial
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FIGURE 2 | Schematic representation of the physiological generation and function of lipid mediators in immunity. Injury to the tissue due to infection, nutritional,
metabolic, or mechanical causes results on secretion of phospholipase A2 which acts on the phospholipid layer of the cell membrane generating arachidonic acid
(AA). Arachidonic acid is the substrate from which the biologically active lipid mediators belonging to the eicosanoid family are produced due to the activity of enzymes
belonging to three families (A) the COX pathway (COX1 COX2) resulting in production of prostaglandins (B) the LOX pathway (5-LOX, 1LOX, 15LOX) resulting in
production of leukotriens and lipoxins, and (C) the cytochrome p450 pathway which forms the hydroxyeicosotetranoic acids and the epoxyeicosotrienoic acids. In
addition (D) Non-enzymatic lipid peroxidation of AA results in the production of isoprostanes and isoketals. All these lipd mediators have a wide range of biologically
significant functions which impact immunity.

level of lipid mediators (Dietzold et al., 2015). Virulent strains
of Mtb are known to enhance production of leukotriens while
suppressing cyclooxygenase (COX)2-induced PGE2 synthesis,
which drives the cells toward necrosis (Rocca and Fitzgerald,
2002; Chen et al., 2008). Moreover, it is known that Mtb
also utilizes host ceramide, which reduces the capacity of
aveolar macrophages to clear apoptotic cells leading to persistent
inflammation (Mattos et al., 2011). Of interest, ceramides are
a known antagonist of foam cell formation via decreased
transport of CD36 to the macrophage cell membrane (Chistiakov
et al., 2016), therefore utilizing the host ceramide supply could
indirectly drive foam cell formation and disease progression.

infections in the chronic phase (Agard et al., 2013), although
augmentation of PGE2 levels reportedly improves protection
against Mtb in the acute stages of infection (Mayer-Barber
et al., 2014). Apart from PGE2, another area gaining importance
in mycobacterial research in recent years is the lipoxygenase
pathway. Mice deficient in 5-LOX were found to be more
resistant to Mtb infection (Bafica et al., 2005; Chen et al., 2008).
Moreover, LOX-derived eicosanoids are known to regulate DC
maturation and function as well as a neutrophilic recruitment
cascade during Mtb infection (Rothe et al., 2015; Mishra and
Sassetti, 2016). Zebra fish larvae deficient in LTA4 hydrolase were
found to have enhanced susceptibility to M. marinum during the
chronic phase of infection, due to the utilization of eicosanoid
substrates leading to the production of anti-inflammatory
lipoxins and an increase in TNF-α levels (Tobin et al., 2010,
2012). Hence, it is likely that these pathways/mediators might
have a differential effect depending on the stage of infection
which could in turn define the final disease outcome.
Inhibition of apotosis is a mechanism by which mycobacteria
can persist in the host and this is also reported to occur at the

Frontiers in Cellular and Infection Microbiology | www.frontiersin.org

Cytokines Involved in Modulating Host
Lipid Metabolism in Mtb Infection
Mycobacterial lipid antigens are known to both enhance
as well as suppress secretion of pro-inflammatory cytokines
such as TNF-α, interleukin (IL)-1α, IL-1β, and IL-6 by host
macrophages (Lee et al., 2007; Thirunavukkarasu et al., 2013,
2017b; Howard et al., 2018). However, the role of these
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FIGURE 3 | Similarities in formation and progression of atherosclerotic plaques and tuberculous granulomas. In atherosclerosis, LDLs accumulate in the arterial
intima, undergo modification by oxidation to form oxLDL which act as chronic stimulators of the innate and adaptive immune response. OxLDL is taken up by the
macrophages via scavenger receptors forming foam cells. The plaque is composed of neutrophils, platelets, T cells, and DC along with foam cells and resultant
secretion of pro-inflammatory cytokines that accentuate inflammation. Apoptosis and secondary necrosis of foam cells and SMCs result in necrotic core development,
degradation of the collagen layer forming unstable plaque that eventually ruptures resulting in bad prognosis. Mtb infection is also characterized by foam cell formation
which is crucial for bacterial peristence. The cellular composition of TB granulomatous lesions includes infected and uninfected macrophages, foamy macrophages, B
and T lymphocytes, neutrophils, platelets, T cells, and fibroblasts. The production of inflammatory cytokines and necrosis of the lipid laden foam cells at the
granulomatous core result in disorganization of the granuloma favoring dissemination of bacteria worsening the prognosis.

well as miR342-5p which suppresses the sterol biosynthetic
pathway (Robertson et al., 2016). The lipophilic sterol metabolites
produced by IFN signaling including oxysterols are substrates for
Cyp enzymes and they profoundly influence cellular metabolism
(Newmark et al., 2017) which in turn has been shown to
influence Mtb replication inside cells (Huang et al., 2018). Since
cytokine modulation of host-lipid metabolism seems to have a
profound influence in mycobacterial persistance detailed studies
to delineate the signaling mechanisms involved is recommended.

cytokines in altering host lipid metabolism and promoting
macrophage foam cell formation during Mtb infection has not
been addressed. In contrast, both type I and type II interferon
(IFN)-induced alterations in host lipid metabolism leading to
either mycobacterial persistence or protective immunity has
been previously addressed (Donovan et al., 2017; Knight et al.,
2018). While type II signaling is associated with protective
immunity and lipid droplet formation involving PGE2 and LXB4,
type I (Knight et al., 2018), signaling suppresses IL-1β induced
protective PGE2 conferring susceptibility to mycobacterial
infection (Mayer-Barber and Yan, 2016).
Recently there has been a renewed interest in the role of
type I interferons in affecting de novo cholesterol and fatty acid
synthesis as well as influencing uptake of exogenous lipids by cells
during the course of infectious diseases (Blanc et al., 2011, 2013;
York et al., 2016). The role of type I IFN in specific cellular subsets
is also being explored with recent reports claiming that pDCs
(plasmacytoid dendritic cells) which characteristically produce
copious type I IFN (Swiecki and Colonna, 2015) alter cellular
metabolism by increasing fatty acid oxidation and oxidative
phosphorylation, which is mediated in an autocrine manner by
the type I IFN secreted (Wu et al., 2016). Moreover, type I IFN
signaling via signal transducer and activator of transcription 1
(STAT-1) enhances expression of the cholesterol 25 hydroxylase
(ch25h) gene and production of 25-hydroxy cholesterol as

Frontiers in Cellular and Infection Microbiology | www.frontiersin.org

TB Granuloma and Host Lipid Metabolism
During disease progression in TB, granuloma is formed locally in
the affected lungs. While a a solid granuloma is often associated
with efficient containment of Mtb, a caseous granuloma is
believed to favor rupture and dissemination of bacteria that likely
results in clinical TB symptoms (Ehlers and Schaible, 2012).
However, the underlying pathology at the site of infection that
determines progresssion to active TB is yet to be fully estalished.
Research focused in identifying the cellular mechanisms within
TB granuloma have determined that host genes for lipid
sequestration, synthesis, and metabolism are upregulated in
caseous pulmonary TB granulomas (Kim et al., 2010). Moreover,
biochemical analysis of these caseous granulomas identified
LDL-derived host lipids such as cholesterol, cholesteryl esters,
lactosylceramides, and TAG (Kim et al., 2010). In a different
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mycobacterial ABC transport proteins and phospholipases has
been explored (Braibant et al., 2000; Glass et al., 2017), the
importance of host ABC proteins in mycobacterial diseases could
be further explored. Recently Long et al. profiled the plasma
membrane of macrophages infected with Mtb and reported an
upregulation of ABCA1 which is involved in cholesterol efflux
from the macrophages (Long et al., 2016). Similarly, few studies
have reported on the importance of other transporters/receptors
such as MARCO for induction of TNF-α, IL-1β, IL-6, and
other responses to mycobacterial trehalose dimycolate and Mtb
(Benard et al., 2014; Thuong et al., 2016; Khan et al., 2017).
These avenues could be explored further in the context of TB
disease reactivation.
IL-6 is a key cytokine induced by Angiotensin-II which
is involved in the development of several CVDs including
atherosclerosis (Schieffer et al., 2004; Kokje et al., 2016;
Akita et al., 2017). IL-6 causes an increase in macrophage
uptake of oxLDL via increase in expression of scavenger
receptors such as SR-A, lectin-like OxLDL receptor-I, and
CD36 (Keidar et al., 2001; Hashizume and Mihara, 2012).
Mycobacteria, as well as their cell wall components, have been
established to induce IL-6 production by varying cell types
including macrophages, dendritic cells, and platelets (Adams
and Czuprynski, 1994; Champsi et al., 1995; Jang et al., 2004).
Apart from systemic production of IL-6, its expression locally
at the granulomatous lesion has been reported by Renshaw
et al. who have confirmed that thrombocytosis associated
with Mtb infection in the granuloma was accompanied
by elevated levels of IL-6 (Renshaw and Gould, 2013).
Moreover, mycobacteria infected murine macrophages
reportedly produce 10,000-fold more IL-6 compared to
uninfected controls (Vanheyningen et al., 1997). Therefore,
it would be worthwhile to assess how IL-6 is associated with
mycobacteria-induced foam cell formation and Mtb survival in
a non-replicative state.
Among the lipid mediators, isoprostanes and isoketals
produced by lipid peroxidation of AA have been studied in
detail in CVD pathogenesis (Cracowski and Ormezzano, 2004;
Roberts and Milne, 2009; Kirabo et al., 2014). F2 isoprostanes
containing oxidized phospholipids rapidly adduct to the amino
group of lysine residue of cell membrane proteins disrupting
their structural and functional capacity resulting in cellular
dysfunction (Brame et al., 2004; Sullivan et al., 2010). Isoketals
in particular are highly cytotoxic and their production is
enhanced by oxidative stress (Kirabo et al., 2014). Since the
immune response to mycobacterial infection is characterized by
an oxidative burst, it is likely that these agents are generated
within the inflammatory milieu during infection which might
influence the disease progression and outcome, however their
importance in TB has not been explored. Isoketals increase
binding and uptake of LDL (Sullivan et al., 2010) and thus
also promote foam cell formation which is an important
criterion promoting mycobacterial survival. Moreover, isoketals
have a role in DC activation by crosslinking lysine residues
on proteins, altering protein function causing them to become
antigenic (Brame et al., 2004; Kirabo et al., 2014) which
might be a source of persistant uncontrolled inflammation

perspective, it is also known that mycobacterial infection
results in enhanced PPAR expression and resultant lipid droplet
formation in the host macrophages (Almeida et al., 2012). This
is believed to occur via the utilization of TAG resulting in the
limiting of bacterial replication while promoting drug tolerance
of Mtb inside foamy macrophages, which is a mechanism of
disease perpetuation (Daniel et al., 2011). Moreover, Mtb is
known to modulate the kinetics of cholesterol metabolism in host
macrophages mainly by enhancing the expression of macrophage
LXR (liver X receptor) genes, which eventually increases bacterial
replication inside the foamy macrophages in granulomatous
lesions (Vermeulen et al., 2017). In addition, the presence of
an association between vitamin D receptor (VDR) and lipid
metabolism in human tuberculosis and infected macrophages
has also been reported (Salamon et al., 2014). When infected
macrophages were treated with vitamin D, the accumulation
of lipid droplets was abolished via a mechanism that involved
VDR mediated downregulation of the proadipogenic PPARγ in
infected macrophages. Also administration of PPARγ agonists
reversed the antiadipogenic as well as the antimicrobial effects of
VDR, thus establishing a role for vitamin D in macrophage lipid
metabolism (Salamon et al., 2014).
Therefore, manipulation of the endogenous lipid mediators
discussed above as well as cytokines involved in altering the
lipid metabolic pathway of the host during mycobacterial
infections has started to gain importance in studies addressing
mycobacterial pathogenesis with the aim of identifying targets for
vaccine development and drug discovery.

CARDIOVASCULAR DISEASE TO
MYCOBACTERIAL INFECTION:
RESEARCH AVENUES TO EXTRAPOLATE
AND EXPLORE
Since macrophages are the primary cell type involved in foam
cell formation in atherosclerosis and mycobacterial infections,
the biogenesis of macrophage foam cell formation may likely
be similar. While many of the receptors and enzymes involved
in foam cell formation have been extensively researched in
relation to CVD (Schumacher and Benndorf, 2017) their
application in relation to mycobacterial pathogenicity is not yet
fully understood.

Lipid Transporters, Cytokines, Lipid
Mediators, and Foam Cell Research
Since mycobacteria are intracellular pathogens often infecting
macrophages, the contribution of macrophage foam cell
formation to mycobacterial pathogenesis has been addressed.
However, there are several areas which could benefit from the
application of relevant knowledge available in the CVD field.
For example, the ABC transport proteins not only play a role
in lipid transport in host macrophages but in Mtb a total of
26 complete ABC transporters have been cataloged with many
of the ABC exporters potentially implicated in the transport
of drugs, probably contributing to the resistance of Mtb to
many antibiotics (Braibant et al., 2000). While the role of
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epithelioid-like multinucleated giant foam cells of the suppressive
phenotype (Feng et al., 2014). However, other aspects of plateletmediated signaling cascades and associated alterations in lipid
metabolism including the activation state of platelets, their
interaction with monocyte subsets and T cells driving foam cell
formation and/or antigen presentation and adaptive immunity
during mycobacterial infections are avenues which could be
further explored utilizing literature available in depth in this area
in CVD research as guidelines.

aggravating pulmonary tissue destruction resulting in fibrotic
development (Mont et al., 2016).

Alternate Cell Types: Platelets
The importance of platelets in inflammation mediated diseases
and disorders including atherosclerosis, arthritis, and cancer has
now been established (Ferrer-Acosta et al., 2014; Papapanagiotou
et al., 2016). Platelets have the capacity to facilitate inflammatory
cell infiltration at the lesion site resulting in the release of a
milieu of inflammatory mediators (Stokes and Granger, 2012).
Moreover, in atherosclerosis LDL initiates a platelet-mediated
signaling cascade and facilitates foam cell formation. Platelets
initiate maturation of macrophages promoting internalization
of oxLDL via scavenger receptors aiding in the formation of
foam cells (Huo et al., 2003; Siegel-Axel et al., 2006; Von
Hundelshausen and Weber, 2007; Von Hundelshausen and
Schmitt, 2014). Interaction of platelets with monocytes results
in an increase in the circulating population of CD14hi CD16+
monocytes in humans (Passacquale et al., 2011; Tapp et al., 2011)
and these are the subpopulations that generally transform to
foam cells, as enzymatically degraded LDL preferentially binds to
these cells via enhanced CD36 expression (Kapinsky et al., 2001).
In a study by Huo et al. it was observed that injecting activated
platelets resulted in the adhesion of monocytes to atherosclerotic
lesions, leading to a reduction in the number of circulating
monocytes, which suggests that platelet-monocyte adhesion plays
a role in the formation of atherosclerotic lesions (Huo et al.,
2003). Therefore, platelets are even being targeted for therapeutic
development to reduce atherosclerosis and atherothrombosis
(Lindemann et al., 2001, 2007).
One of the first studies assessing the direct involvement of
platelets in bacterial pathogenesis was by Sullam et al. who
reported through activation of the COX pathway and resultant
production of thromboxane A2, platelets could directly kill
Streptococcus sanguis in vitro (Sullam et al., 1993). Although
the role of macrophages and T cells in protection against
mycobacteria has been well-established (Ernst, 2012), the role
of platelets in mycobacterial infections has lagged behind and
the importance of these cells in relation to TB pathogenesis
has gained priority only in the recent past (Lugo-Villarino
and Neyrolles, 2014). Pulmonary TB due to Mtb infection is
now associated with increased platelet infiltration and activity,
coupled with enhanced platelet interaction with monocytes and
T cells in granulomas, stressing a critical role for these cells in TB
pathogenesis (Renshaw and Gould, 2013; Kullaya et al., 2018).
In atherosclerosis, apart from macrophages, other cell types
including smooth muscle cells and endothelial cells lining the
blood vessel can also transform into foam cells (Glukhova et al.,
1987; Ivan and Antohe, 2010). Similarly, whether other cell types
present locally at the site of granuloma formation eg. alveolar
cells, airway smooth muscle cells (in Mtb infection) or intestinal
smooth muscle cells (in M. paratuberculosis infection) could
form foam cells and how that would drive the disease course
has not been addressed. In this context the role of platelets
in host lipid metabolism during mycobacterial infection was
only recently addressed, wherein platelets were found to have
the capacity to initiate the differentiation of monocytes into
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Cytochrome P450 (Cyp) System
The Cyp system has been implicated in the pathogenesis of
various CVDs including atherosclerosis and aneurysms (Song
et al., 2016; Thirunavukkarasu et al., 2016b). The Cyp enzymes
are heme containing monooxygenases involved in the pathways
associated with the metabolism of fatty acids, steroids and other
lipophilic molecules (Pikuleva, 2008). The loss of Cyp enzymes
prevents Apolipoprotein (Apo) A1 synthesis thus affecting the
removal of cholesterol from the cells to the liver for biliary
excretion (Rubin et al., 1991; Nebert and Russell, 2002; Guan
et al., 2003). The cholesterol metabolizing ability of Cyp family
members varies depending on the physiological requirements of
different organs and in vivo cholesterol levels. Since the activity
of the Cyp enzymes can be modulated post-translationally, they
are targets to manipulate cholesterol homeostasis (Luoma, 2008).
The importance of Cyp in mycobacteria is known. For
example, Mtb has about 20 different Cyp enzymes, and several
Cyp genes have been associated with mycobacterial viability
(Mclean et al., 2010). Cole et al. have reported that the Mtb
genome sequence has a very high number of Cyp enzymes, with
Cyp128 contributing to synthesis of cell wall sulpholipid and
being necessary for in-vitro growth of the bacterium (Cole et al.,
1998; Holsclaw et al., 2008; Sogi et al., 2016). Iron is necessary
for mycobacterial Cyp (Ouellet et al., 2002, 2011) activity and
iron has been recognized as a crucial element for the survival
of intracellular mycobacteria (Ratledge, 2004; Janagama et al.,
2009; Lamont et al., 2013). Thus, the importance of Cyp from the
pathogen perspective has been explored albeit not in depth.
From the host perspective, a transcriptomic analysis of TB
granulomas has revealed a characteristic downregulation of
several Cyp genes in cells within these granulomas (Eisenreich
et al., 2013). Cyp monooxygenases are involved in biosynthesis
of oxysterols (Pikuleva, 2006, 2008), however the dynamics
between the expression of Cyp genes in granuloma formation and
cholesterol metabolism has not been assessed in Mtb infection.

Cyp450 and Steroid Sex Hormones
Physiologically occurring steroid hormones which impact sexual
characteristics are lipids that are synthesized from cholesterol in
the gonads and adrenal glands. These sex steroid hormones have
additional functions influencing metabolism, inflammation and
immune responses. Apart from their direct role in modulating
host cholesterol metabolism, members of the Cyp family such
as Cyp4501b1(Cyp1b1) are involved in the metabolism of sex
steroidal hormones with the resultant metabolites produced
being implicated to play a role in the gender differences noticed
to the susceptibility to cardiac and renal diseases (Jennings
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et al., 2014; Pingili et al., 2015, 2016; Song et al., 2016;
Thirunavukkarasu et al., 2016b). While Cyp1b1 has been shown
to have a protective role against cardiac and renal diseases in
females, it aggravates the pathogenesis of these diseases in males,
due to the action of this enzyme on estrogen and testosterone,
respectively, as shown by ovariectomy and castration studies
(Jennings et al., 2014; Pingili et al., 2016, 2017).
Sexual dimorphism in the relative susceptibility to Mtb and
other mycobacterial infections has been reported, with the male
to female ratio of susceptibility to Mtb infection reported to
be 1.9/0.6 worldwide (Yamamoto et al., 1991; Neyrolles and
Quintana-Murci, 2009; Karunasena et al., 2014; Nhamoyebonde
and Leslie, 2014). Both in humans and animal models it has
been shown that the male gender is more susceptible to TB
than the female gender, and the differences in sex hormones
could be a possible underlying mechanism for this difference
(Svanberg, 1981; Tsuyuguchi et al., 2001; Ramsey et al., 2006;
Dibbern et al., 2017). Intact female and castrated male mice have
reduced severity of M. avium, M. marinum, and M. intracellulare
infection, while ovariectomized females, or females and castrated
males treated with testosterone had increased susceptibility to
infection (Yamamoto et al., 1991; Tsuyuguchi et al., 2001).
These findings have translational significance as in humans the
death rate in castrated males due to TB was less compared
to intact males and pre-menopausal females (Hamilton and
Mestler, 1969). Moreover, there is almost a 2-fold increase in
the severe lepromatous form of tuberculoid leprosy in males
compared to females (Guerra-Silveira and Abad-Franch, 2013).
These studies suggest that sex steroidal hormones might have a
role in influencing the susceptibility to mycobacterial infections
in mammals. Therefore, extrapolating from the evidence for
Cyp1b1 in gender specific pathogeneis of CVDs, it would be
worthwhile to explore further the role of Cyp family members
in mycobacterial infections due to a necessity for a sex-tailored
therapeutic approach in view of the gender related susceptibility
to disease.

Santucci et al. (2016). Thus, incorporating the recent advances
in in vitro technology employed in CVD research to study foam
cell signaling in mycobacterial research should prove fruitful.

CONCLUSIONS
Decrease in cholesterol efflux, increase in uptake, and excess
esterification of cholesterol compounded by the action of lipid
peroxidation products generated by inflammatory processes
contribute to foam cell formation in atherosclerosis. Since these
are critical events in the pathogenesis of atherosclerosis, they
have been extensively studied. On the contrary, although a
role for host lipid metabolism in mycobacterial pathogenesis
has been established, research in the different components
that contribute to the alteration in host lipid metabolism
and cholesterol homeostasis is still in the nascent stages. The
specific cause for reactivation of mycobacterial disease from a
controlled state in an infected host is still a critical question
that remains inconclusive. It is speculated that the reversible
lipid accumulation in foamy macrophages could be a possible
phenomenon that is associated with disease reactivation (CaireBrändli et al., 2014). Researchers attempting to decipher these
loopholes in TB pathogenesis specifically targeting the host lipid
pathway with the aim of developing novel therapeutics and
vaccination strategies would be better served by utilizing the
plethora of resources available in this area in the cardiovascular
field (Kurth et al., 2004; Han et al., 2017; Rodriguez et al.,
2017). The potential for PPAR regulators of airway inflammation
as potential therapeutic targets for asthma and lung diseases
(Standiford et al., 2005; Banno et al., 2018) has already been
explored and their application for TB therapeutics could be
further explored. Some studies have already reported on the
application of statins and COX-2 inhibitors as adjuncts in the
therapeutic strategy of mycobacterial infections which could be
further exlpored in depth (Turull and Queralt, 2000; Brombacher
et al., 2013; Lobato et al., 2014). Thus, extrapolation and
application of relevant knowledge and techniques between these
fields would prove to be beneficial and sustainable amidst an
increasingly competitive research scenario beset by time and
funding constraints.

Technology Transfer
3D in vitro technology employing scaffolds made of biomaterials
that could be engineered to simulate tissue degeneration or
regeneration has revolutionized biomedical research in CVD
medicine (Ou and Hosseinkhani, 2014). Such models could
be employed in mycobacterial research as well, to assess,
understand, and decipher novel mechanisms involved in the
pathogenesis of these bacteria in a dynamic sense. Positive
steps in this direction were initiated by devising a three
dimensional in vitro granuloma mode utilizing PBMCs to
study host-pathogen interactions, drug susceptibility as well as
mycobacterial drug tolerance and persistence (Kapoor et al.,
2013; Fitzgerald et al., 2014). Since foam cell formation is
associated with Mtb survival during infection research in in vitro
models of Mtb-infected foam cells is critical. Novel methods to
generate and evaluate foam cells in vitro have been utilized in
the CVD research field (Xu et al., 2010; Sengupta et al., 2013),
and these techniques could be applied to assess the interaction
of mycobacteria with foam cells under controlled conditions to
gain a better understanding of the events that lead to persistence
of the bacterium in a non-replicative state as reported by
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org
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